Van Der Hoeven P C, Van Der Wal J C, Ruurs P, Van Dijk M C, Van Blitterswijk J
Division of Cellular Biochemistry, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.
Biochem J. 2000 Jan 15;345 Pt 2(Pt 2):297-306. doi: 10.1042/0264-6021:3450297.
14-3-3 Proteins may function as adapters or scaffold in signal-transduction pathways. We found previously that protein kinase C-zeta (PKC-zeta) can phosphorylate and activate Raf-1 in a signalling complex [van Dijk, Hilkmann and van Blitterswijk (1997) Biochem. J. 325, 303-307]. We report now that PKC-zeta-Raf-1 interaction is mediated by 14-3-3 proteins in vitro and in vivo. Co-immunoprecipitation experiments in COS cells revealed that complex formation between PKC-zeta and Raf-1 is mediated strongly by the 14-3-3beta and -theta; isotypes, but not by 14-3-3zeta. Far-Western blotting revealed that 14-3-3 binds PKC-zeta directly at its regulatory domain, where a S186A mutation in a putative 14-3-3-binding domain strongly reduced the binding and the complex formation with 14-3-3beta and Raf-1. Treatment of PKC-zeta with lambda protein phosphatase also reduced its binding to 14-3-3beta in vitro. Preincubation of an immobilized Raf-1 construct with 14-3-3beta facilitated PKC-zeta binding. Together, the results suggest that 14-3-3 binds both PKC-zeta (at phospho-Ser-186) and Raf-1 in a ternary complex. Complex formation was much stronger with a kinase-inactive PKC-zeta mutant than with wild-type PKC-zeta, supporting the idea that kinase activity leads to complex dissociation. 14-3-3beta and -θ were substrates for PKC-zeta, whereas 14-3-3zeta was not. Phosphorylation of 14-3-3beta by PKC-zeta negatively regulated their physical association. 14-3-3beta with its putative PKC-zeta phosphorylation sites mutated enhanced co-precipitation between PKC-zeta and Raf-1, suggesting that phosphorylation of 14-3-3 by PKC-zeta weakens the complex in vivo. We conclude that 14-3-3 facilitates coupling of PKC-zeta to Raf-1 in an isotype-specific and phosphorylation-dependent manner. We suggest that 14-3-3 is a transient mediator of Raf-1 phosphorylation and activation by PKC-zeta.
14-3-3蛋白可能在信号转导途径中作为衔接蛋白或支架发挥作用。我们之前发现蛋白激酶C-ζ(PKC-ζ)能在一个信号复合物中磷酸化并激活Raf-1[范·迪克、希尔克曼和范·布利特斯维克(1997年)《生物化学杂志》第325卷,303 - 307页]。我们现在报告,在体外和体内,PKC-ζ与Raf-1的相互作用是由14-3-3蛋白介导的。在COS细胞中进行的共免疫沉淀实验表明,PKC-ζ与Raf-1之间的复合物形成主要由14-3-3β和-θ亚型介导,而不是由14-3-3ζ介导。Far-Western印迹法显示,14-3-3在PKC-ζ的调节结构域直接与其结合,在一个假定的14-3-3结合结构域中的S186A突变显著降低了其与14-3-3β和Raf-1的结合及复合物形成。用λ蛋白磷酸酶处理PKC-ζ也降低了其在体外与14-3-3β的结合。用14-3-3β预孵育固定化的Raf-1构建体促进了PKC-ζ的结合。总之,结果表明14-3-3在一个三元复合物中同时结合PKC-ζ(在磷酸化丝氨酸-186处)和Raf-1。与激酶失活的PKC-ζ突变体相比,复合物形成在激酶失活的PKC-ζ突变体中要强得多,这支持了激酶活性导致复合物解离的观点。14-3-3β和-θ是PKC-ζ的底物,而14-3-3ζ不是。PKC-ζ对14-3-3β的磷酸化负向调节它们的物理缔合。其假定的PKC-ζ磷酸化位点发生突变的14-3-3β增强了PKC-ζ与Raf-1之间的共沉淀,表明PKC-ζ对14-3-3的磷酸化在体内削弱了复合物。我们得出结论,14-3-3以一种亚型特异性和磷酸化依赖性的方式促进PKC-ζ与Raf-1的偶联。我们认为14-3-3是PKC-ζ介导的Raf-1磷酸化和激活的瞬时介质。